Great-West Lifeco stock reports 19.3 percent Q2 ROE

Published on 10/01/2026 at 04:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Analysts put the average 12-month target at CAD 93.27 on September 26, 2026. Q2 figures show CAD 1.42 EPS and CAD 8.35 billion revenue.

GWO, CA39138C1068, Illustration mit AI erstellt.

Great-West Lifeco stock is anchored by a 19.3 percent return on equity in Q2 2026, above the company's 19 percent medium-term target. The insurer and asset manager also delivered quarterly EPS of CAD 1.42 and revenue of CAD 8.35 billion, according to MarketBeat on September 26, 2026.

Q2 returns beat the target

The 19.3 percent ROE gives the latest quarter a clear benchmark: it exceeded the 19 percent medium-term objective by 0.3 percentage points. Investing.com reported on September 10, 2026 that capital-light businesses represented 66 percent of earnings and management expects that share to rise above 70 percent over the planning period.

The operating mix matters because capital-light earnings are expected to support further ROE expansion. The same transcript said Empower's retirement operating margin reached 34.7 percent in Q2 2026, while workplace client assets exceeded CAD 2 trillion.

Analysts set a CAD 93.27 target

MarketBeat said 12 analysts had a Moderate Buy consensus on September 26, 2026, comprising seven buy ratings, four holds and one strong buy. Their average 12-month price target was CAD 93.27, while recent targets reached CAD 100.00.

On the Toronto Stock Exchange, the stock stood at CAD 89.87 on September 30, 2026 at 4:00 p.m. EDT, versus a prior close of CAD 90.74. The same dated quote showed a market capitalization of CAD 80.5 billion and a 52-week range of CAD 55.72 to CAD 95.96.

Next report is November 4

TradingView lists November 4, 2026 as the next reporting date for Q3 2026. Its estimate is CAD 1.45 EPS, giving investors a defined checkpoint after the 19.3 percent Q2 ROE and the CAD 8.35 billion quarterly revenue figure.